Development of a new pentaplex real-time PCR assay for the identification of poly-microbial specimens containing Staphylococcus aureus and other staphylococci, with simultaneous detection of staphylococcal virulence and methicillin resistance markers

Molecular and Cellular Probes
Charles E OkolieRichard James

Abstract

Staphylococcus aureus strains harbouring genes encoding virulence and antibiotic resistance are of public health importance. In clinical samples, pathogenic S. aureus is often mixed with putatively less pathogenic coagulase-negative staphylococci (CoNS), both of which can harbour mecA, the gene encoding staphylococcal methicillin-resistance. There have been previous attempts at distinguishing MRSA from MRCoNS, most of which were based on the detection of one of the pathognomonic markers of S. aureus, such as coa, nuc or spa. That approach might suffice for discrete colonies and mono-microbial samples; it is inadequate for identification of clinical specimens containing mixtures of S. aureus and CoNS. In the present study, a real-time pentaplex PCR assay has been developed which simultaneously detects markers for bacteria (16S rRNA), coagulase-negative staphylococcus (cns), S. aureus (spa), Panton-Valentine leukocidin (pvl) and methicillin resistance (mecA). Staphylococcal and non-staphylococcal bacterial strains (n = 283) were used to validate the new assay. The applicability of this test to clinical samples was evaluated using spiked blood cultures (n = 43) containing S. aureus and CoNS in mono-microbial and poly-microbial mod...Continue Reading

References

Sep 18, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D JohnssonB Söderquist
Feb 15, 2005·Biochemical and Biophysical Research Communications·Saori NakagawaTatsuo Yamamoto
Apr 9, 2005·The New England Journal of Medicine·Henry F Chambers
Jan 20, 2007·Science·Maria Labandeira-ReyM Gabriela Bowden
Jul 13, 2007·Journal of Clinical Microbiology·J Michael Janda, Sharon L Abbott
Mar 2, 2012·Journal of Clinical Microbiology·Feng-Jui ChenUNKNOWN TSAR Hospitals
Jul 21, 2012·Journal of Clinical Microbiology·Senda Mezghani MaalejAdnene Hammami
Dec 18, 2013·Nature Reviews. Microbiology·Timothy J FosterMagnus Höök

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.